Near-Infrared Light-Triggered NO Nanogenerator for Gas-Enhanced Photodynamic Therapy and Low-Temperature Photothermal Therapy to Eliminate Biofilms
DOI: https://doi.org/10.2147/ijn.s454762
IF: 7.033
2024-06-13
International Journal of Nanomedicine
Abstract:Junjuan Li, 1, &ast Yue Tian, 2, &ast Qi Qin, 2, &ast Zhaolei Ding, 1 Xue Zhao, 3 Wei Tan 1 1 Department of Respiratory Medicine, The First Affiliated Hospital of Weifang Medical University/Weifang People's Hospital, Weifang, 261000, People's Republic of China; 2 School of Clinical Medicine, Weifang Medical University, Weifang, 261053, People's Republic of China; 3 Department of Laboratory Medicine, The First Affiliated Hospital of Weifang Medical University/Weifang People's Hospital, Weifang, 261000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wei Tan, Department of Respiratory Medicine, Weifang People's Hospital, 151 Guangwen Street, Weifang, Shandong Province, 261000, People's Republic of China, Email Xue Zhao, Department of Laboratory Medicine, Weifang People's Hospital, 151 Guangwen Street, Weifang, Shandong Province, 261000, People's Republic of China, Email Purpose: Owing to its noninvasive nature, broad-spectrum effectiveness, minimal bacterial resistance, and high efficiency, phototherapy has significant potential for antibiotic-free antibacterial interventions and combating antibacterial biofilms. However, finding effective strategies to mitigate the detrimental effects of excessive temperature and elevated concentrations of reactive oxygen species (ROS) remains a pressing issue that requires immediate attention. Methods: In this study, we designed a pH-responsive cationic polymer sodium nitroside dihydrate/branched polyethylenimine–indocyanine green@polyethylene glycol (SNP/PEI-ICG@PEG) nanoplatform using the electrostatic adsorption method and Schiff's base reaction. Relevant testing techniques were applied to characterize and analyze SNP/PEI-ICG@PEG, proving the successful synthesis of the nanomaterials. In vivo and in vitro experiments were performed to evaluate the antimicrobial properties of SNP/PEI-ICG@PEG. Results: The morphology and particle size of SNP/PEI-ICG@PEG were observed via TEM. The zeta potential and UV-visible (UV‐vis) results indicated the synthesis of the nanomaterials. The negligible cytotoxicity of up to 1 mg/mL of SNP/PEI-ICG@PEG in the presence or absence of light demonstrated its biosafety. Systematic in vivo and in vitro antimicrobial assays confirmed that SNP/PEI-ICG@PEG had good water solubility and biosafety and could be activated by near-infrared (NIR) light and synergistically treated using four therapeutic modes, photodynamic therapy (PDT), gaseous therapy (GT), mild photothermal therapy (PTT, 46 °C), and cation. Ultimately, the development of Gram-positive (G + ) Staphylococcus aureus ( S. aureus ) and Gram-negative (G − ) Escherichia coli ( E. coli ) were both completely killed in the free state, and the biofilm that had formed was eliminated. Conclusion: SNP/PEI-ICG@PEG demonstrated remarkable efficacy in achieving controlled multimodal synergistic antibacterial activity and biofilm infection treatment. The nanoplatform thus holds promise for future clinical applications. Keywords: cationic, mild photothermal, photodynamic, NO gas, antibacterial Bacteria have coevolved with humans in symbiotic relationship based on mutual dependence. 1–3 When the human immune system is compromised due to factors such as exposure to cold temperatures, fatigue, or illnesses, the probability of bacterial infection significantly increases. The severity of infection primarily relies on the virulence of bacteria and may involve biofilm formation. Biofilms, as umbrellas for free-living bacteria, are microcommunities of large number of free-living bacteria encapsulated in the extracellular polymeric substance (EPS) they produce. Biofilms tend to resist the host's immune system, reduce antibiotic susceptibility, and impede antibiotic leakage, making them difficult to treat. Biofilms have been reported to be up to 1,000 times more resistant to antibiotics than bacteria in the free state. 3–6 The presence of biofilms, the development of bacterial resistance, and the long lead time for new antibiotic development make it necessary to reduce the overreliance on antibiotics. 7,8 Efforts to develop new antimicrobial agents that are less prone to resistance and have effective bactericidal properties are important for advancing future antimicrobial research. With the progress of nanomedicine, an increasing number of nanomaterials and innovative antibacterial therapies have been employed for antibacterial treatment research. Previously investigated nanomaterials include precious metal nanoparticles, carbon-based nanomaterials, organic small-molecule nanomat -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology